uridine diphosphate has been researched along with Leukemia, Myelomonocytic, Chronic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benikhlef, N; Ciudad, M; Droin, N; Ducoroy, P; Dufour, E; Fenaux, P; Fontenay, M; Guery, L; Hendra, JB; Jacquel, A; Jooste, V; Kosmider, O; Pecqueur, D; Quesnel, B; Racoeur, C; Solary, E; Truntzer, C | 1 |
1 other study(ies) available for uridine diphosphate and Leukemia, Myelomonocytic, Chronic
| Article | Year |
|---|---|
Alpha-defensins secreted by dysplastic granulocytes inhibit the differentiation of monocytes in chronic myelomonocytic leukemia.
Topics: alpha-Defensins; CD24 Antigen; Cell Differentiation; Cytokines; Granulocytes; Humans; Leukemia, Myelomonocytic, Chronic; Lipopolysaccharide Receptors; Macrophage Colony-Stimulating Factor; Macrophages; Monocytes; Receptors, Purinergic P2; Uridine Diphosphate; Uridine Triphosphate | 2010 |